Budget 2020: Current health concerns warrant greater budgetary backing for innovation and …

Greater investment in biological sciences is crucial because we are in times when both non-communicable diseases (like cancer and diabetes) and infectious diseases (caused by new viruses) are only going to riseKiran Mazumdar-Shaw        Last Updated: January 31, 2020  | 00:32 IST There is much to hope for from this Budget, especially for the Indian healthcare sector. Take… Continue reading Budget 2020: Current health concerns warrant greater budgetary backing for innovation and …

Strides Pharma Science Q3 net declines 69% to Rs 92 crore

The consolidated income of the company increased to Rs 744.66 crore in the Oct-Dec period.PTI|Last Updated: Jan 30, 2020, 01.06 PM ISTGetty ImagesThe company had posted consolidated profit of Rs 296.43 crore in the year-ago period, Strides Pharma Science said in a regulatory filing. Drug firm Strides Pharma Science on Thursday posted 68.8 per cent… Continue reading Strides Pharma Science Q3 net declines 69% to Rs 92 crore

D-Street Buzz: Pharma stocks tumble, Aurobindo Pharma falls 4%; YES Bank, Zee Ent drag

The Indian equity market has been jilted by the outbreak of the coronavirus in China spooking investors fearing that the virus outbreak may derail the pace of economic growth.The market sentiment is nervous with Sensex down 221.90 points or 0.54 percent at 40976.76 while the Nifty shed 66.50 points at 12063.All sectoral indices are trading in the red led by… Continue reading D-Street Buzz: Pharma stocks tumble, Aurobindo Pharma falls 4%; YES Bank, Zee Ent drag

USFDA cautions Aurobindo Pharma’s oral solids formulation facility of regulatory action

The company stressed that it will work closely with the US Food and Drug Administration (USFDA) to comprehensively address the issues. Representative image Drug firm Aurobindo Pharma on Thursday reported that the US health regulator has cautioned that its oral solids formulation manufacturing facility may be subject to regulatory actions.The company stressed that it will… Continue reading USFDA cautions Aurobindo Pharma’s oral solids formulation facility of regulatory action

Cipla sets up chemistry research lab at IISER Pune

The lab aims to provide practical training in Chemistry to undergraduates and researchers Cipla Foundation, the social responsibility arm of Cipla Ltd, has funded the set-up of a chemistry research laboratory at the Indian Institute of Science Education and Research (IISER) Pune. The lab aims to provide practical training in Chemistry to undergraduates and researchers… Continue reading Cipla sets up chemistry research lab at IISER Pune

UPDATE 2-Johnson & Johnson working on vaccine for deadly coronavirus

Johnson & Johnson on Wednesday became the latest drugmaker to begin work on developing a vaccine for a new coronavirus that has already killed more than 100 people in China, as health authorities race to contain the outbreak. J&J said its vaccine program would utilize the same technologies used to make its experimental Ebola vaccine,… Continue reading UPDATE 2-Johnson & Johnson working on vaccine for deadly coronavirus

Cipla Foundation sets up a dedicated state-of-the-art chemistry laboratory at IISER Pune

Pune: In continuance of its efforts to advance quality education and promote industry-academia collaboration, Cipla Foundation, the social responsibility arm of Cipla Ltd, has funded the set-up of a world class chemistry research laboratory at the Indian Institute of Science Education and Research (IISER) Pune. The lab aims to provide practical training in Chemistry to… Continue reading Cipla Foundation sets up a dedicated state-of-the-art chemistry laboratory at IISER Pune

Pharma firms brace for raw material supply issues due to coronavirus outbreak

Pharmaceutical companies in India are bracing for a hit on supply of key raw materials, majority of which is imported from China, if the current outbreak of novel coronavirus infection continues. “We buy antibiotics and vitamins in a big way from them (Chinese manufacturers). As of now, there is no problem but we will have… Continue reading Pharma firms brace for raw material supply issues due to coronavirus outbreak

Sai Life Sciences Commences Recruitment of 300+ Scientists for its Upcoming Integrated …

HYDERABAD, India, Jan. 29, 2020 /PRNewswire/ — Sai Life Sciences, one of India’s fastest growing Contract Development & Manufacturing Organizations (CDMOs), today announced that it has initiated the recruitment of 300+ scientists for its upcoming integrated Research & Technology (R&T) centre in Hyderabad, India. This will result in doubling the full-time equivalents (FTEs) in the… Continue reading Sai Life Sciences Commences Recruitment of 300+ Scientists for its Upcoming Integrated …

Alembic Pharmaceuticals gets USFDA Approval for Azithromycin Tablets

Alembic Pharmaceuticals announces USFDA Final Approval for Azithromycin Tablets USP, 600 mg. Alembic Pharmaceuticals Limited (Alembic) has announced it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Azithromycin Tablets USP, 600 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product… Continue reading Alembic Pharmaceuticals gets USFDA Approval for Azithromycin Tablets